BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34710701)

  • 21. MITF E318K's effect on melanoma risk independent of, but modified by, other risk factors.
    Berwick M; MacArthur J; Orlow I; Kanetsky P; Begg CB; Luo L; Reiner A; Sharma A; Armstrong BK; Kricker A; Cust AE; Marrett LD; Gruber SB; Anton-Culver H; Zanetti R; Rosso S; Gallagher RP; Dwyer T; Venn A; Busam K; From L; White K; Thomas NE;
    Pigment Cell Melanoma Res; 2014 May; 27(3):485-8. PubMed ID: 24406078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PGC-1 coactivators regulate MITF and the tanning response.
    Shoag J; Haq R; Zhang M; Liu L; Rowe GC; Jiang A; Koulisis N; Farrel C; Amos CI; Wei Q; Lee JE; Zhang J; Kupper TS; Qureshi AA; Cui R; Han J; Fisher DE; Arany Z
    Mol Cell; 2013 Jan; 49(1):145-57. PubMed ID: 23201126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.
    Carreira S; Goodall J; Denat L; Rodriguez M; Nuciforo P; Hoek KS; Testori A; Larue L; Goding CR
    Genes Dev; 2006 Dec; 20(24):3426-39. PubMed ID: 17182868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the long terminal repeat of human endogenous retrovirus K by melanoma-specific transcription factor MITF-M.
    Katoh I; Mírová A; Kurata S; Murakami Y; Horikawa K; Nakakuki N; Sakai T; Hashimoto K; Maruyama A; Yonaga T; Fukunishi N; Moriishi K; Hirai H
    Neoplasia; 2011 Nov; 13(11):1081-92. PubMed ID: 22131883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of MITF on melanoma development: news from bench and bedside.
    Roider EM; Fisher DE
    J Invest Dermatol; 2014 Jan; 134(1):16-17. PubMed ID: 24352080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations.
    Potrony M; Puig-Butille JA; Aguilera P; Badenas C; Tell-Marti G; Carrera C; Javier Del Pozo L; Conejo-Mir J; Malvehy J; Puig S
    JAMA Dermatol; 2016 Apr; 152(4):405-12. PubMed ID: 26650189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.
    Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A
    Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.
    Keenen B; Qi H; Saladi SV; Yeung M; de la Serna IL
    Oncogene; 2010 Jan; 29(1):81-92. PubMed ID: 19784067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A common intronic variant of PARP1 confers melanoma risk and mediates melanocyte growth via regulation of MITF.
    Choi J; Xu M; Makowski MM; Zhang T; Law MH; Kovacs MA; Granzhan A; Kim WJ; Parikh H; Gartside M; Trent JM; Teulade-Fichou MP; Iles MM; Newton-Bishop JA; Bishop DT; MacGregor S; Hayward NK; Vermeulen M; Brown KM
    Nat Genet; 2017 Sep; 49(9):1326-1335. PubMed ID: 28759004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. UCHL1 Regulates Melanogenesis through Controlling MITF Stability in Human Melanocytes.
    Seo EY; Jin SP; Sohn KC; Park CH; Lee DH; Chung JH
    J Invest Dermatol; 2017 Aug; 137(8):1757-1765. PubMed ID: 28392346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vulvar Melanoma in association with germline MITF p.E318K variant.
    Koeller DR; Schwartz A; DeSimone MS; Rana HQ; Rojas-Rudilla V; Russell-Goldman E; Laga AC; Lindeman NI; Garber JE; Ghazani AA
    Cancer Genet; 2022 Apr; 262-263():102-106. PubMed ID: 35220194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-148 regulates Mitf in melanoma cells.
    Haflidadóttir BS; Bergsteinsdóttir K; Praetorius C; Steingrímsson E
    PLoS One; 2010 Jul; 5(7):e11574. PubMed ID: 20644734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanoma.
    Fernández-Barral A; Orgaz JL; Baquero P; Ali Z; Moreno A; Tiana M; Gómez V; Riveiro-Falkenbach E; Cañadas C; Zazo S; Bertolotto C; Davidson I; Rodríguez-Peralto JL; Palmero I; Rojo F; Jensen LD; del Peso L; Jiménez B
    Neoplasia; 2014 Jun; 16(6):529-42. PubMed ID: 25030625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between variants of the CREB1 and GRM7 genes and risk of depression.
    Wang L; Tang X; Liang P; Zhou C; Sun Y; Liang Y
    BMC Psychiatry; 2023 Jan; 23(1):3. PubMed ID: 36597080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for an alternatively spliced MITF exon 2 variant.
    Simmons JL; Pierce CJ; Boyle GM
    J Invest Dermatol; 2014 Apr; 134(4):1166-1168. PubMed ID: 24226203
    [No Abstract]   [Full Text] [Related]  

  • 36. Cooperative antiproliferative signaling by aspirin and indole-3-carbinol targets microphthalmia-associated transcription factor gene expression and promoter activity in human melanoma cells.
    Poindexter KM; Matthew S; Aronchik I; Firestone GL
    Cell Biol Toxicol; 2016 Apr; 32(2):103-19. PubMed ID: 27055402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression.
    He S; Li CG; Slobbe L; Glover A; Marshall E; Baguley BC; Eccles MR
    Melanoma Res; 2011 Feb; 21(1):24-34. PubMed ID: 21164369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TYRP1 mRNA level is stable and MITF-M-independent in drug-naïve, vemurafenib- and trametinib-resistant BRAF
    Hartman ML; Czyz M
    Arch Dermatol Res; 2020 Jul; 312(5):385-392. PubMed ID: 31624899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer risks associated with the germline MITF(E318K) variant.
    Guhan SM; Artomov M; McCormick S; Njauw C-; Stratigos AJ; Shannon K; Ellisen LW; Tsao H
    Sci Rep; 2020 Oct; 10(1):17051. PubMed ID: 33051548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic characterization of nevus and tumor patterns in MITF E318K mutation carrier melanoma patients.
    Sturm RA; Fox C; McClenahan P; Jagirdar K; Ibarrola-Villava M; Banan P; Abbott NC; Ribas G; Gabrielli B; Duffy DL; Peter Soyer H
    J Invest Dermatol; 2014 Jan; 134(1):141-149. PubMed ID: 23774529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.